ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 659

IL-17 Producing T Cells and Its Dichotomy: A Mixed Response of the Innate and Acquired Immune System in Psoriatic Arthritis

Siba P. Raychaudhuri1 and Smriti K. Raychaudhuri2, 1Rheumatology Section, Sacramento Veterans Affairs Medical Center, Sacramento, CA, 2Rheumatology/Immunology, VA Sacramento Medical Center, Davis, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: IL-23, innate immunity and psoriatic arthritis, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

 Background/Purpose:     Source of IL-17 in human has been mainly attributed to ab T cells, more specifically to the Th17 cells. However, some reports suggest that cells of the innate immune system: γd T cells and NKT cells may be the major contributing IL-17 producing cells in psoriatic arthritis (PsA).  To have a definite answer; here we have studied arrays of IL-17 producing T cell phenotypes in PsA including the Mucosal associated invariant T (MAIT) cells. 

Methods:

•        PBMC and synovial fluid mononuclear cells (SFMC) from age/sex matched active PsA patients (n=15) and normal individuals (n=15) were collected 

•        Patients were not on DMARDS or biologics

•        rIL-23 induced activated IL-17+ T cells were generated and stained as per our earlier reports (Raychaudhuri SP, etal. Mol Cell Biochem. 2012 ;359:419-29 ).

•        Hi-D FACS studies were done to identify the activated memory effector CD11a+CD45RO+IL-17+ T cells. MAIT cells were CD3+Vα7.2TCR+CD161high, γd T cells were CD3+γdTCR+, ab T cells were CD3+abTCR+, invariant CD1d-restricted natural killer (NK) T cells were CD1d/PBS-57 tetramer+CD3+. The percentages of each cell population and the mean fluorescence intensity (MFI) were analyzed using FlowJo software.                    

Results:

The percentage of IL-17+ CD3+ T cells was far higher in both PBMC (20­­.5 ± 0.5%) and SFMC (43± 0.7% ) in PsA patients  compared to 3± 0.5% in PBMC of healthy persons (p<0.001).

Both PBMC and SFMC in PsA patients demonstrated IL-17+ effector memory T cells (TEM) in the following T cell phenotypes: ab T cells, γd T cells, NKT cells and MAIT cells. The frequency of these CD3+IL-17+ T cells in the PBMC and SFMC in PsA patients are described in the Table-1 (Table 1).  An important observation we noticed that IL-17+ MAIT cell in SFMC were enriched (5%) compared to 1 % in PBMC and they were predominantly CD8+ (~ 90%).

Conclusion:

· In PsA, pathologic CD11a+CD45RO+IL-17+ T cells are comprised of cells of both the innate and acquired immune response:   ab T cells, γd T cells, MAIT cells and NKT cells.  

·  However, compared to the other phenotypes, the dominant (~ 80%) IL-17+T cells in PsA (both in PBMC and SFMC) were conventional T-helper 17 (Th17) CD4+CD11a+CD45RO+abTCR+ T cells (p<0.001%) (Table 1).   

· MHC class-1 association, subclinical colitis and enrichment of Tc17 CD8+/MAIT cells in SFMC in PsA could be of additional pathological significance and needs further evaluation.

Table 1.  IL-17 expression (%) in gated CD3+CD11a+CD45RO+ T cells in different T cell phenotypes in SFMC and PBMC of PsA. αβTCR IL-17+ cells are significantly more than NKT, MAIT and γdTCR, p<0.001.

 

 

Table-1

PBMC (% + SD)

SFMC (%+ SD)

NKT

15.155 ± 1.275

17.012 ± 2.362

MAIT

1.995 ± 0.089

5.182 ± 0.251

dgTCR

2.907 ± 0.469

1.391 ± 0.229

baTCR

79.943 ± 1.112

76.496 ± 0.224

 

 

 

 

 

 


Disclosure: S. P. Raychaudhuri, None; S. K. Raychaudhuri, None.

To cite this abstract in AMA style:

Raychaudhuri SP, Raychaudhuri SK. IL-17 Producing T Cells and Its Dichotomy: A Mixed Response of the Innate and Acquired Immune System in Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/il-17-producing-t-cells-and-its-dichotomy-a-mixed-response-of-the-innate-and-acquired-immune-system-in-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-17-producing-t-cells-and-its-dichotomy-a-mixed-response-of-the-innate-and-acquired-immune-system-in-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology